BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Afexa Life Sciences Inc. 

Corporate Office
9604 20th Avenue
Edmonton  Alberta  T6N 1G1  Canada
Phone: 780-432-0022 Fax: 780-432-7772


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





 Company News
Evidera Announces Release FDA Draft Guidance On Use Of The "EXACT" To Measure Symptoms Of COPD Exacerbations 1/14/2014 10:53:53 AM    More...
Valeant Pharmaceuticals International (VRX) Announces the Completion of the Privatization of Afexa Life Sciences Inc. 12/13/2011 9:01:01 AM    More...
Valeant Pharmaceuticals International (VRX) Announces Take-Up of Additional Afexa Life Sciences Inc. Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization 10/28/2011 10:47:58 AM    More...
Valeant Pharmaceuticals International (VRX) Announces Results of Friendly Offer for Afexa Life Sciences Inc. 10/18/2011 6:01:38 AM    More...
Valeant Pharmaceuticals International (VRX) Announces That Afexa Life Sciences Inc. Supports and Recommends Valeant's Increased Offer and Agrees to Certain Amendments to Support Agreement 10/3/2011 5:55:45 AM    More...
Valeant Pharmaceuticals International (VRX) Trumps Paladin Labs Inc. (CC:PLB) for Afexa Life Sciences Inc. With $78 Million Bid 9/26/2011 8:04:39 AM    More...
Valeant Pharmaceuticals International (VRX) Nabs Afexa Life Sciences Inc. for $76 Million Cash; Beats Paladin Labs Inc. (CC:PLB) to the Punch 8/30/2011 7:15:00 AM    More...
Afexa Life Sciences Inc. Asks Shareholders to Reject Hostile Paladin Labs Inc. (CC:PLB) Bid 8/24/2011 6:46:02 AM    More...
Paladin Labs Inc. (CC:PLB) Makes Takeover Bid for Afexa Life Sciences Inc. Worth $56.7 Million 8/10/2011 8:08:16 AM    More...
Afexa Life Sciences Inc. Announces CEO Succession Process 6/24/2011 7:59:44 AM    More...
12

//-->